Centrosome amplification drives chromosomal instability in breast tumor development

Wilma L. Lingle, Susan L. Barrett, Vivian C. Negron, Antonio D'Assoro, Kelly Boeneman, Wanguo Liu, Clark M. Whitehead, Carol Reynolds, Jeffrey L Salisbury

Research output: Contribution to journalArticle

431 Citations (Scopus)

Abstract

Earlier studies of invasive breast tumors have shown that 60-80% are aneuploid and ≈80% exhibit amplified centrosomes. In this study, we investigated the relationship of centrosome amplification with aneuploidy, chromosomal instability, p53 mutation, and loss of differentiation in human breast tumors. Twenty invasive breast tumors and seven normal breast tissues were analyzed by fluorescence in situ hybridization with centromeric probes to chromosomes 3, 7, and 17. We analyzed these tumors for both aneuploidy and unstable karyotypes as determined by chromosomal instability. The results were then tested for correlation with three measures of centrosome amplification: centrosome size, centrosome number, and centrosome microtubule nucleation capacity. Centrosome size and centrosome number both showed a positive, significant, linear correlation with aneuploidy and chromosomal instability. Microtubule nucleation capacity showed no such correlation, but did correlate significantly with loss of tissue differentiation. Centrosome amplification was detected in in situ ductal carcinomas, suggesting that centrosome amplification is an early event in these lesions. Centrosome amplification and chromosomal instability occurred independently of p53 mutation, whereas p53 mutation was associated with a significant increase in centrosome microtubule nucleation capacity. Together, these results demonstrate that independent aspects of centrosome amplification correlate with chromosomal instability and loss of tissue differentiation and may be involved in tumor development and progression. These results further suggest that aspects of centrosome amplification may have clinical diagnostic and/or prognostic value and that the centrosome may be a potential target for cancer therapy.

Original languageEnglish (US)
Pages (from-to)1978-1983
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume99
Issue number4
DOIs
StatePublished - Feb 19 2002

Fingerprint

Centrosome
Chromosomal Instability
Breast Neoplasms
Aneuploidy
Microtubules
Mutation
Neoplasms
Chromosomes, Human, Pair 17
Chromosomes, Human, Pair 3
Chromosomes, Human, Pair 7
Carcinoma, Intraductal, Noninfiltrating
Fluorescence In Situ Hybridization
Karyotype

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Centrosome amplification drives chromosomal instability in breast tumor development. / Lingle, Wilma L.; Barrett, Susan L.; Negron, Vivian C.; D'Assoro, Antonio; Boeneman, Kelly; Liu, Wanguo; Whitehead, Clark M.; Reynolds, Carol; Salisbury, Jeffrey L.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, No. 4, 19.02.2002, p. 1978-1983.

Research output: Contribution to journalArticle

Lingle, Wilma L. ; Barrett, Susan L. ; Negron, Vivian C. ; D'Assoro, Antonio ; Boeneman, Kelly ; Liu, Wanguo ; Whitehead, Clark M. ; Reynolds, Carol ; Salisbury, Jeffrey L. / Centrosome amplification drives chromosomal instability in breast tumor development. In: Proceedings of the National Academy of Sciences of the United States of America. 2002 ; Vol. 99, No. 4. pp. 1978-1983.
@article{9d7dd96338f841168ea8bd4c60330d6a,
title = "Centrosome amplification drives chromosomal instability in breast tumor development",
abstract = "Earlier studies of invasive breast tumors have shown that 60-80{\%} are aneuploid and ≈80{\%} exhibit amplified centrosomes. In this study, we investigated the relationship of centrosome amplification with aneuploidy, chromosomal instability, p53 mutation, and loss of differentiation in human breast tumors. Twenty invasive breast tumors and seven normal breast tissues were analyzed by fluorescence in situ hybridization with centromeric probes to chromosomes 3, 7, and 17. We analyzed these tumors for both aneuploidy and unstable karyotypes as determined by chromosomal instability. The results were then tested for correlation with three measures of centrosome amplification: centrosome size, centrosome number, and centrosome microtubule nucleation capacity. Centrosome size and centrosome number both showed a positive, significant, linear correlation with aneuploidy and chromosomal instability. Microtubule nucleation capacity showed no such correlation, but did correlate significantly with loss of tissue differentiation. Centrosome amplification was detected in in situ ductal carcinomas, suggesting that centrosome amplification is an early event in these lesions. Centrosome amplification and chromosomal instability occurred independently of p53 mutation, whereas p53 mutation was associated with a significant increase in centrosome microtubule nucleation capacity. Together, these results demonstrate that independent aspects of centrosome amplification correlate with chromosomal instability and loss of tissue differentiation and may be involved in tumor development and progression. These results further suggest that aspects of centrosome amplification may have clinical diagnostic and/or prognostic value and that the centrosome may be a potential target for cancer therapy.",
author = "Lingle, {Wilma L.} and Barrett, {Susan L.} and Negron, {Vivian C.} and Antonio D'Assoro and Kelly Boeneman and Wanguo Liu and Whitehead, {Clark M.} and Carol Reynolds and Salisbury, {Jeffrey L}",
year = "2002",
month = "2",
day = "19",
doi = "10.1073/pnas.032479999",
language = "English (US)",
volume = "99",
pages = "1978--1983",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "4",

}

TY - JOUR

T1 - Centrosome amplification drives chromosomal instability in breast tumor development

AU - Lingle, Wilma L.

AU - Barrett, Susan L.

AU - Negron, Vivian C.

AU - D'Assoro, Antonio

AU - Boeneman, Kelly

AU - Liu, Wanguo

AU - Whitehead, Clark M.

AU - Reynolds, Carol

AU - Salisbury, Jeffrey L

PY - 2002/2/19

Y1 - 2002/2/19

N2 - Earlier studies of invasive breast tumors have shown that 60-80% are aneuploid and ≈80% exhibit amplified centrosomes. In this study, we investigated the relationship of centrosome amplification with aneuploidy, chromosomal instability, p53 mutation, and loss of differentiation in human breast tumors. Twenty invasive breast tumors and seven normal breast tissues were analyzed by fluorescence in situ hybridization with centromeric probes to chromosomes 3, 7, and 17. We analyzed these tumors for both aneuploidy and unstable karyotypes as determined by chromosomal instability. The results were then tested for correlation with three measures of centrosome amplification: centrosome size, centrosome number, and centrosome microtubule nucleation capacity. Centrosome size and centrosome number both showed a positive, significant, linear correlation with aneuploidy and chromosomal instability. Microtubule nucleation capacity showed no such correlation, but did correlate significantly with loss of tissue differentiation. Centrosome amplification was detected in in situ ductal carcinomas, suggesting that centrosome amplification is an early event in these lesions. Centrosome amplification and chromosomal instability occurred independently of p53 mutation, whereas p53 mutation was associated with a significant increase in centrosome microtubule nucleation capacity. Together, these results demonstrate that independent aspects of centrosome amplification correlate with chromosomal instability and loss of tissue differentiation and may be involved in tumor development and progression. These results further suggest that aspects of centrosome amplification may have clinical diagnostic and/or prognostic value and that the centrosome may be a potential target for cancer therapy.

AB - Earlier studies of invasive breast tumors have shown that 60-80% are aneuploid and ≈80% exhibit amplified centrosomes. In this study, we investigated the relationship of centrosome amplification with aneuploidy, chromosomal instability, p53 mutation, and loss of differentiation in human breast tumors. Twenty invasive breast tumors and seven normal breast tissues were analyzed by fluorescence in situ hybridization with centromeric probes to chromosomes 3, 7, and 17. We analyzed these tumors for both aneuploidy and unstable karyotypes as determined by chromosomal instability. The results were then tested for correlation with three measures of centrosome amplification: centrosome size, centrosome number, and centrosome microtubule nucleation capacity. Centrosome size and centrosome number both showed a positive, significant, linear correlation with aneuploidy and chromosomal instability. Microtubule nucleation capacity showed no such correlation, but did correlate significantly with loss of tissue differentiation. Centrosome amplification was detected in in situ ductal carcinomas, suggesting that centrosome amplification is an early event in these lesions. Centrosome amplification and chromosomal instability occurred independently of p53 mutation, whereas p53 mutation was associated with a significant increase in centrosome microtubule nucleation capacity. Together, these results demonstrate that independent aspects of centrosome amplification correlate with chromosomal instability and loss of tissue differentiation and may be involved in tumor development and progression. These results further suggest that aspects of centrosome amplification may have clinical diagnostic and/or prognostic value and that the centrosome may be a potential target for cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=0037133211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037133211&partnerID=8YFLogxK

U2 - 10.1073/pnas.032479999

DO - 10.1073/pnas.032479999

M3 - Article

VL - 99

SP - 1978

EP - 1983

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 4

ER -